Docket Management
Docket: 02N-0466 - Randomized Dose Response Study of Dryvax in Children Ages 2 to 5
Comment Number: EC -94

Accepted - Volume 3

Comment Record
Commentor Mr. Robert Vircks Date/Time 2002-11-02 15:39:57
Organization Mr. Robert Vircks
Category Individual

Comments for FDA General
Questions
1. General Comments The study should be approved. So long as we want to do things based on facts and data we must run the tests to get that information. In my mind it is a certainty that we will be subject to bioterror attack. The committed individual will most certainly take advantage of whatever opportunity that presents itself. To the extent that we are unwilling to assume that children are little adults then we must test them to get the facts. Go for it.




EC -94